DSGN

Design Therapeutics (DSGN)

Design Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:DSGN

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/09	05:31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DSGN	Design Therapeutics Inc
2024/05/09	05:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DSGN	Design Therapeutics Inc
2024/05/09	05:05	GlobeNewswire Inc.	Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones	NASDAQ:DSGN	Design Therapeutics Inc
2024/05/07	19:30	GlobeNewswire Inc.	Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference	NASDAQ:DSGN	Design Therapeutics Inc
2024/03/20	05:01	GlobeNewswire Inc.	Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:DSGN	Design Therapeutics Inc
2024/03/19	20:27	IH Market News	US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat	NASDAQ:DSGN	Design Therapeutics Inc
2024/03/12	19:30	GlobeNewswire Inc.	Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update	NASDAQ:DSGN	Design Therapeutics Inc
2024/01/06	06:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2024/01/06	06:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2023/12/06	08:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2023/11/14	06:14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DSGN	Design Therapeutics Inc
2023/11/14	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DSGN	Design Therapeutics Inc
2023/11/14	06:05	GlobeNewswire Inc.	Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024	NASDAQ:DSGN	Design Therapeutics Inc
2023/09/07	06:13	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:DSGN	Design Therapeutics Inc
2023/08/31	07:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2023/08/31	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2023/08/26	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DSGN	Design Therapeutics Inc
2023/08/15	05:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DSGN	Design Therapeutics Inc
2023/08/15	05:05	GlobeNewswire Inc.	Design Therapeutics Provides Pipeline Update and Reports Second Quarter 2023 Financial Results	NASDAQ:DSGN	Design Therapeutics Inc
2023/08/15	05:01	GlobeNewswire Inc.	Design Therapeutics Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich Ataxia	NASDAQ:DSGN	Design Therapeutics Inc
2023/06/03	05:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DSGN	Design Therapeutics Inc
2023/06/03	05:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DSGN	Design Therapeutics Inc
2023/06/03	05:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DSGN	Design Therapeutics Inc
2023/06/03	05:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DSGN	Design Therapeutics Inc
2023/06/03	05:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DSGN	Design Therapeutics Inc
2023/06/03	05:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DSGN	Design Therapeutics Inc
2023/06/02	05:46	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DSGN	Design Therapeutics Inc
2023/05/31	19:30	GlobeNewswire Inc.	Design Therapeutics to Present at the 2023 Jefferies Healthcare Conference	NASDAQ:DSGN	Design Therapeutics Inc
2023/05/10	05:14	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DSGN	Design Therapeutics Inc
2023/05/10	05:05	GlobeNewswire Inc.	Design Therapeutics Provides Pipeline Updates and Reports First Quarter 2023 Financial Results	NASDAQ:DSGN	Design Therapeutics Inc